A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the safety and effectiveness of risperidone (an
antipsychotic medication) in adolescents with schizophrenia over 6 months of treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.